Andrea Bacigalupo
Unit for Hematology and BMT, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy · Fondazione Policlinico Gemelli IRCCS · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrea Bacigalupo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:08 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04709458 · Safety and Early Efficacy Study of TBX-2400 in Patients With AML or MyelofibrosisTaiga Biotechnologies, Inc. · unknown · Myelofibrosis, Acute Myelogenous Leukemia · principal investigator
- Ph2NCT04166929 · Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDSFondazione Policlinico Universitario Agostino Gemelli IRCCS · terminated · Acute Myeloid Leukemia, Myelodysplasia · principal investigator
- Ph2NCT03902665 · Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75Fondazione Policlinico Universitario Agostino Gemelli IRCCS · completed · Acute Myeloid Leukemia, Adult · principal investigator
- Ph3NCT02411084 · Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHDAdienne SA · terminated · Graft vs Host Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:08 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:08 UTC. The ranking covers the 200 most relevant of 121 PubMed records, and a shared surname and initials can bring in a namesake. All 121 on PubMed
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.Lancet · 20082,090 citationsRCR 52.2
- Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.Biol Blood Marrow Transplant · 2005621 citationsRCR 14.5
- 456 citationsRCR 10.6
- 432 citationsRCR 8.0
- Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.Biol Blood Marrow Transplant · 2013307 citationsRCR 10.1
- Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.Biol Blood Marrow Transplant · 2006304 citationsRCR 8.1
- 270 citationsRCR 7.8
- Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy.N Engl J Med · 1992253 citationsRCR 9.8
- 244 citationsRCR 6.0
- Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation.Bone Marrow Transplant · 1998223 citationsRCR 5.8